Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022

SELL
$0.17 - $0.34 $55,386 - $110,772
-325,800 Reduced 28.55%
815,200 $155,000
Q1 2022

May 16, 2022

SELL
$0.25 - $0.43 $87,175 - $149,941
-348,700 Reduced 23.41%
1,141,000 $359,000
Q4 2021

Feb 14, 2022

BUY
$0.34 - $1.0 $118,320 - $348,000
348,000 Added 30.48%
1,489,700 $521,000
Q3 2021

Nov 15, 2021

BUY
$0.96 - $1.62 $1.1 Million - $1.85 Million
1,141,700 New
1,141,700 $1.1 Million

Others Institutions Holding CWBR

# of Institutions
1
Shares Held
1.14K
Call Options Held
0
Put Options Held
0

About CohBar, Inc.


  • Ticker CWBR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,906,940
  • Market Cap $1.19M
  • Description
  • CohBar, Inc., a clinical stage biotechnology company, focuses in the research and development of mitochondria based therapeutics (MBTs) for the treatment of chronic and age-related diseases. The company develops MBTs to treat non-alcoholic steatohepatitis (NASH), obesity, fatty liver disease, idiopathic pulmonary fibrosis, type 2 diabetes, acute...
More about CWBR
Track David A. Siegel's Portfolio

Track David A. Siegel Portfolio

Follow David A. Siegel (Two Sigma Advisers, LP) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Advisers, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Advisers, LP and David A. Siegel with notifications on news.